Artex renames cell facility as Artex Axcell 

Artex, Gallagher's wholly owned subsidiary for alternative risk and capital, has created Artex Axcell and will be transitioning all of its cell facility names to Axcell over the next several months.

Artex said the change a...

Want to read this article?

Register for ultimate access to this article and ALL our premium content


  • Unrestricted access to Commercial Risk, Commercial Risk Europe and Global Risk Manager news, exclusive expert analysis and opinion
  • Breaking news, daily and/or weekly Commercial Risk Europe newsletters and regular digital publications
  • Breaking news, weekly and monthly Global Risk Manager newsletters and quarterly digital Journal
  • European and global surveys, rankings and special reports
  • National European local language newsletters
  • Preferential access to webinars and virtual and physical conferences

If you are already a registered user or subscriber you can LOGIN below for ultimate access:

Back to top button